Earlier quoted context omitted.
They have trialled variant specific vaccines for both Delta and Omicron. It turned out that the original vaccine is as effective for Delta, so that work was shelved. Omicron, on the other hand, seems to be evading the immunity created by the Alpha vaccine, so they are actually planning to start producing an Omicron specific booster (or more correctly Alpha+Omicron) after FDA approval.
> They have trialled variant specific vaccines for both Delta and Omicron. It turned out that the original vaccine is as effective for Delta, so that work was shelved. No, it wasn't; in fact, the Pfizer-BioNtech Omicron variant-specifc vaccine and booster trial was announced only a week ago, while Novavax plans to begin testing an Omicron-specific vaccine imminently. https://www.pfizer.com/news/press-release/press-re…
I said "for Delta". If you read the rest of my comment I mentioned the upcoming Omicron vaccine too.